Abstract:Background Metabolic syndrome (MetS) and its components are associated with increased risks of several cancers. However, the relationship between MetS and upper tract urothelial carcinoma (UTUC) has never been investigated before. Methods We identified 3,785 UTUC cases aged over 65 years old within the Surveillance, Epidemiology and End Results-Medicare database between 2007 and 2016. For comparison, non-cancer controls (n = 189,953) were selected from the 5% random sample of individuals residing within regions of SEER registries and matched with cases through diagnosis date and pseudo-diagnosis date. MetS and its components were all defined by using ICD-9-CM codes. Multivariate logistic regression models were conducted to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Time trends for MetS and its components were reported and we also performed dose-response effect analysis to test the concomitant effect of these components. The study was presented following the STROBE reporting checklist. Results UTUC risk was associated with metabolic syndrome (NCEP-III: OR: 1.669, 95% CI: 1.550–1.792; IDF: OR: 1.924, 95% CI: 1.676–2.172) and its component factors: elevated waist circumference/central adiposity (OR: 1.872, 95% CI: 1.693–2.055), impaired fasting glucose (OR: 1.306, 95% CI: 1.133–1.480), high blood pressure (OR: 1.295, 95% CI: 1.239–1.353), high triglycerides (OR: 1.280, 95% CI: 1.222–1.341), and low high-density lipoprotein cholesterol (OR: 1.354, 95% CI: 1.118–1.592). Consistent associations could also be observed in the subgroup analyses by tumor stages, grades, and tumor size. Additionally, the rates of MetS increased over time in both UTUC and control cohort (NCEP-III criterion; EAPC: +18.1%, P < 0.001; EAPC: +16.1%, P < 0.001, respectively). A significantly gradual increase in UTUC rates could be seen as the No. of the MetS components increase ( χ 2 = 37.239, P trend = 0.000). Conclusions Among people aged over 65, MetS and its components were significant risk factors for UTUC with consistent associations in different tumor stages, grades, and tumor size. Even if a subject who did not meet the criteria for MetS had only one of the components, he (she) still had an elevated risk for UTUC. Strategies to control the epidemic of MetS and its components might contribute to a reduction in the UTUC burden. The findings should be considered tentative until ascertained by more researches.

Association of metabolic syndrome and its components with the risk of kidney cancer: A cohort-based case-control study.

Association between metabolic syndrome and kidney cancer risk: a prospective cohort study

Metabolic Syndrome Components and the Risk of Colorectal Cancer: A Population-Based Prospective Study in Chinese Men.

Metabolic Syndrome and Risk of Pancreatic Cancer: A Population-Based Prospective Cohort Study.

Association between metabolic syndrome and the risk of colorectal cancer: a prospective study in China

Metabolic Syndrome and Risk of Upper Tract Urothelial Carcinoma: A Case-Control Study From Surveillance, Epidemiology and End Results-Medicare-Linked Database

[Association of Metabolic Syndrome and Colorectal Cancer].

Association of Metabolic Syndrome with Risk of Lung Cancer: A Population-Based Prospective Cohort Study.

Synergism Between the Metabolic Syndrome Components and Cancer Incidence: Results from a Prospective Nested Case–control Study Based on the China Health and Retirement Longitudinal Study (CHARLS)

Metabolic Syndrome and Renal Cell Carcinoma

The Associations of Metabolic Syndrome with Incident Hypertension, Type 2 Diabetes Mellitus and Chronic Kidney Disease: a Cohort Study

Association Between Metabolic Syndrome and Endometrial Cancer Risk: a Systematic Review and Meta-Analysis of Observational Studies

Metabolic Syndrome is Not Associated with Prostate Cancer Recurrence: A Retrospective Analysis of a Chinese Cohort.

Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta‐analysis of 31 prospective cohorts and Mendelian randomization study

Metabolic syndrome is associated with improved cancer-specific survival in patients with localized clear cell renal cell carcinoma

Effects of Metabolic Syndrome and Its Components on Chronic Kidney Disease and Renal Function: A Two-Sample Mendelian Randomization Study

IDDF2019-ABS-0179 the Association Between Components of Metabolic Syndrome and Colorectal Cancer Risk in Chinese Males

The association between metabolic syndrome and renal cell carcinoma

Metabolic Syndrome and Risk of Cancer in Chinese Populations: a Systematic Review and Meta-Analysis in 57 260 Individuals

The association between metabolic syndrome and lung cancer risk: a Mendelian randomization study

Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study